Edison Issues Initiation on International Stem Cell – PR Newswire (press release)
|
Edison Issues Initiation on International Stem Cell
PR Newswire (press release) International Stem Cell (ISCO) is an early-stage cell therapy company currently in Phase I/IIa clinical trials to treat Parkinson's disease (PD). In addition, ISCO sells skincare and biomedical supplies to the market, generating $8m in sales and $1.7m … |
